⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

HIMS

Hims & Hers Health, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

27.71USD

-1.4200 (-4.87%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on HIMS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.06▼$0.0702
Next quarter$0.11▼$0.1701
Current year-$0.56▼-$0.1302
Next year$0.42▼$0.6211

Recent quarters

Beat in 1 of the last 4

QuarterEstimateActualSurprise
2026-06-30-$0.05-$0.37-0.32 (-640.0%)
2026-03-31$0.03-$0.4-0.43 (-1664.3%)
2025-12-31$0.04$0.08+0.04 (+92.5%)
2025-09-30$0.1$0.06-0.04 (-41.0%)

Wall Street coverage

148 ratings from 21 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Truist SecuritiesMaintainedHold$27 $32Aug 24, 2026
BarclaysMaintainedOverweight$39 $35Aug 21, 2026
CitigroupMaintainedNeutral$35 $33Aug 11, 2026
Deutsche BankMaintainedHold$25 $26Aug 11, 2026
B of A SecuritiesMaintainedNeutral$30 $32Aug 11, 2026
TD CowenMaintainedHold$25 $30Aug 11, 2026
Morgan StanleyMaintainedEqual-Weight$21 $28Aug 11, 2026
NeedhamMaintainedBuy$35 $42Aug 11, 2026
Truist SecuritiesMaintainedHold$23 $27Jul 24, 2026
CitigroupMaintainedNeutral$28 $35Jul 23, 2026
B of A SecuritiesMaintainedNeutral$36 $37Jul 9, 2026
Canaccord GenuityMaintainedBuy$32 $40Jul 1, 2026
B of A SecuritiesMaintainedNeutral$25 $36Jul 1, 2026
BarclaysMaintainedOverweight$29 $39Jun 18, 2026
B of A SecuritiesMaintainedNeutral$28 $25May 26, 2026
Truist SecuritiesMaintainedHold$18 $23May 22, 2026
B of A SecuritiesMaintainedNeutral$30 $28May 19, 2026
B of A SecuritiesMaintainedNeutral$32 $30May 13, 2026
CitigroupMaintainedNeutral$24 $28May 12, 2026
JP MorganMaintainedOverweight$35 $33May 12, 2026
BTIGReiteratedNeutral—May 12, 2026
NeedhamMaintainedBuy$30 $35May 12, 2026
JP MorganInitiatedOverweight$35Apr 24, 2026
B of A SecuritiesMaintainedNeutral$30 $32Apr 24, 2026
B of A SecuritiesMaintainedNeutral$21 $25Apr 16, 2026

Insider transactions

166 filings from 19 insiders · 36 buy / 17 sell over 6m

Officers and directors of HIMS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Boughton SoleilOfficer, Chief Legal OfficerSell3.5k$29.06$101kOct 14, 2026
Okupe OluyemiOfficer, Chief Financial OfficerSell2.0k$29.70$59kOct 1, 2026
Boughton SoleilOfficer, Chief Legal OfficerSell3.5k$29.17$101kSep 30, 2026
Okupe OluyemiOfficer, Chief Financial OfficerExercise14.0k$5.01$70kSep 22, 2026
Okupe OluyemiOfficer, Chief Financial OfficerSell29.3k$29.95$877kSep 22, 2026
Okupe OluyemiOfficer, Chief Financial OfficerExerciseStock Option (right to buy)14.0k——Sep 22, 2026
Okupe OluyemiOfficer, Chief Financial OfficerSell12.3k$28.82$355kSep 17, 2026
Boughton SoleilOfficer, Chief Legal OfficerSell6.2k$27.86$174kSep 16, 2026
Chi MichaelOfficer, Chief Operating OfficerSell14.0k$28.39$398kSep 15, 2026
Elshenawy MohamedOfficer, CTOSell8.0k$28.39$226kSep 15, 2026
Boughton SoleilOfficer, Chief Legal OfficerSell3.5k$28.33$98kSep 2, 2026
DUDUM ANDREWChief Executive OfficerGiftindirect463.3k——Aug 25, 2026
OKUPE OLUYEMIChief Financial OfficerSell4.9k$29.99$148kAug 19, 2026
BOUGHTON SOLEILOfficerSell25.1k$27.55$692kAug 19, 2026
OKUPE OLUYEMIChief Financial OfficerExercise4.9k$5.01$25kAug 19, 2026
AUTOR DEBORAH MOfficer and DirectorSell16.8k$27.85$467kAug 18, 2026
OKUPE OLUYEMIChief Financial OfficerExercise81.0k$5.01$47kAug 17, 2026
OKUPE OLUYEMIChief Financial OfficerSell64.8k$27.89$2.21MAug 17, 2026
AUTOR DEBORAH MOfficer and DirectorOther32.9k——Aug 14, 2026
BOUGHTON SOLEILOfficerOther42.3k——Aug 14, 2026

Analyst Notes

Sign in to write

No analyst notes on HIMS yet.

Analyst Ratings

13 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current211200Hold2.67
1 mo ago211101Hold2.80
2 mo ago211101Hold2.80
3 mo ago211200Hold2.67
Price target$31.15$23.00 – $42.00
+12.4% to target

Top voices on HIMS

Members whose judged calls on HIMS have played out most reliably.

No settled calls on HIMS yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice